Home > Financial Ratios > ONESOURCE SPECIALTY PHARMA

ONESOURCE SPECIALTY PHARMA
Price to Cash Earnings (PCE)

    Back to All Ratios
COMMUNITY POLL
for ONESOURCE SPECIALTY PHARMA
Please provide your vote to see the results

ONESOURCE SPECIALTY PHARMA Last 5 Year Price to Cash Earnings (PCE) History

[Standalone]

Mar2025Mar2024Mar2023
   PCE(x) 129.46--

What is the latest Price to Cash Earnings (PCE) ratio of ONESOURCE SPECIALTY PHARMA ?

The latest Price to Cash Earnings (PCE) ratio of ONESOURCE SPECIALTY PHARMA is 129.46 based on Mar2025 Standalone results.
Year Price to Cash Earnings (PCE)
Mar2025129.46
Mar2024-
Mar2023-

How is Price to Cash Earnings (PCE) of ONESOURCE SPECIALTY PHARMA Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 129.46
0
Mar2024 0
0
Mar2023 0 -

Other Financial Ratios of ONESOURCE SPECIALTY PHARMA


Compare Price to Cash Earnings (PCE) ratio of peers of ONESOURCE SPECIALTY PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ONESOURCE SPECIALTY PHARMA ₹21,257.5 Cr 2.7% 1.2% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,452.0 Cr -0.3% 6% -10.5% Stock Analytics
DIVIS LABORATORIES ₹179,089.0 Cr 3.9% 18.6% 14.5% Stock Analytics
CIPLA ₹121,299.0 Cr -5.2% NA 2.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,456.0 Cr -1% -1.2% 8.7% Stock Analytics
DR REDDYS LABORATORIES ₹99,965.9 Cr -6.8% -2.1% -8.4% Stock Analytics


ONESOURCE SPECIALTY PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ONESOURCE SPECIALTY PHARMA

2.7%

1.2%

NA
SENSEX

-0.3%

4.5%

5.7%


You may also like the below Video Courses